 Antibodies, Monoclonal
"Antibodies, Monoclonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies produced by a single clone of cells.
| Descriptor ID |
D000911
|
| MeSH Number(s) |
D12.776.124.486.485.114.224 D12.776.124.790.651.114.224 D12.776.377.715.548.114.224
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Monoclonal".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Monoclonal".
This graph shows the total number of publications written about "Antibodies, Monoclonal" by people in this website by year, and whether "Antibodies, Monoclonal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 13 | 12 | 25 | | 1992 | 5 | 11 | 16 | | 1993 | 3 | 9 | 12 | | 1994 | 4 | 16 | 20 | | 1995 | 5 | 11 | 16 | | 1996 | 4 | 14 | 18 | | 1997 | 3 | 5 | 8 | | 1998 | 1 | 14 | 15 | | 1999 | 7 | 6 | 13 | | 2000 | 7 | 10 | 17 | | 2001 | 12 | 15 | 27 | | 2002 | 7 | 17 | 24 | | 2003 | 10 | 15 | 25 | | 2004 | 13 | 19 | 32 | | 2005 | 18 | 14 | 32 | | 2006 | 16 | 15 | 31 | | 2007 | 26 | 12 | 38 | | 2008 | 17 | 22 | 39 | | 2009 | 36 | 19 | 55 | | 2010 | 30 | 23 | 53 | | 2011 | 16 | 18 | 34 | | 2012 | 14 | 12 | 26 | | 2013 | 12 | 11 | 23 | | 2014 | 33 | 12 | 45 | | 2015 | 11 | 8 | 19 | | 2016 | 18 | 14 | 32 | | 2017 | 21 | 13 | 34 | | 2018 | 24 | 11 | 35 | | 2019 | 15 | 8 | 23 | | 2020 | 11 | 8 | 19 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Monoclonal" by people in Profiles.
-
Poeschla E. Neutralizing SARS-CoV-2. Elife. 2020 12 15; 9.
-
Wang Z, Rahkola J, Redzic JS, Chi YC, Tran N, Holyoak T, Zheng H, Janoff E, Eisenmesser E. Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease. Nat Commun. 2020 11 27; 11(1):6063.
-
Quattrin T, Haller MJ, Steck AK, Felner EI, Li Y, Xia Y, Leu JH, Zoka R, Hedrick JA, Rigby MR, Vercruysse F. Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes. N Engl J Med. 2020 11 19; 383(21):2007-2017.
-
Sawangjit R, Dilokthornsakul P, Lloyd-Lavery A, Lai NM, Dellavalle R, Chaiyakunapruk N. Systemic treatments for eczema: a network meta-analysis. Cochrane Database Syst Rev. 2020 09 14; 9:CD013206.
-
Weisel K, Spencer A, Lentzsch S, Avet-Loiseau H, Mark TM, Spicka I, Masszi T, Lauri B, Levin MD, Bosi A, Hungria V, Cavo M, Lee JJ, Nooka A, Quach H, Munder M, Lee C, Barreto W, Corradini P, Min CK, Chanan-Khan AA, Horvath N, Capra M, Beksac M, Ovilla R, Jo JC, Shin HJ, Sonneveld P, Casneuf T, DeAngelis N, Amin H, Ukropec J, Kobos R, Mateos MV. Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk. J Hematol Oncol. 2020 08 20; 13(1):115.
-
Scott FI. Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch? Dig Dis Sci. 2020 08; 65(8):2158-2160.
-
Edwards RG, Vanderhoof S, Palestine A, Seibold LK. Bilateral Secondary Angle Closure During Daratumumab Infusion: A Case Report and Review of the Literature. J Glaucoma. 2020 08; 29(8):e83-e86.
-
Akturk HK, Michels AW. Adverse events associated with immune checkpoint inhibitors: a new era in autoimmune diabetes. Curr Opin Endocrinol Diabetes Obes. 2020 08; 27(4):187-193.
-
Cunningham CK, McFarland EJ, Morrison RL, Capparelli EV, Safrit JT, Mofenson LM, Mathieson B, Valentine ME, Perlowski C, Smith B, Hazra R, Purdue L, Muresan P, Harding PA, Mbengeranwa T, Robinson LG, Wiznia A, Theron G, Lin B, Bailer RT, Mascola JR, Graham BS. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. J Infect Dis. 2020 07 23; 222(4):628-636.
-
Agazio A, Cimons J, Shotts KM, Guo K, Santiago ML, Pelanda R, Torres RM. Histone H2A-Reactive B Cells Are Functionally Anergic in Healthy Mice With Potential to Provide Humoral Protection Against HIV-1. Front Immunol. 2020; 11:1565.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|